These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12921999)

  • 21. Enzyme-replacement therapy for Gaucher's disease.
    N Engl J Med; 1991 Dec; 325(25):1809-11. PubMed ID: 1944489
    [No Abstract]   [Full Text] [Related]  

  • 22. Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy.
    Perel Y; Bioulac-Sage P; Chateil JF; Trillaud H; Carles J; Lamireau T; Guillard JM
    Pediatrics; 2002 Jun; 109(6):1170-3. PubMed ID: 12042560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].
    Hollak CE; van Oers MH; Maaswinkel P; Aerts JM; Goudsmit R
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1011-3. PubMed ID: 8684492
    [No Abstract]   [Full Text] [Related]  

  • 24. Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy.
    Gornati R; Bembi B; Tong X; Boscolo R; Berra B
    Clin Chim Acta; 1998 Mar; 271(2):151-61. PubMed ID: 9565330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imiglucerase treatment in Gaucher's disease.
    Shah U; Nadeem N; Husen Y; Fadoo Z
    J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical outcomes of 2 pediatric patients with Gaucher's disease in enzyme replacement therapy for 9 years].
    Quijada Fraile P; Martín Hernández E; Teresa García-Silva M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():43-5. PubMed ID: 22230125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.
    Altarescu G; Hill S; Wiggs E; Jeffries N; Kreps C; Parker CC; Brady RO; Barton NW; Schiffmann R
    J Pediatr; 2001 Apr; 138(4):539-47. PubMed ID: 11295718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enzyme therapy of Gaucher's disease].
    Beck M
    Dtsch Med Wochenschr; 1993 Jun; 118(25):964-5. PubMed ID: 8519225
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gaucher disease type 1--therapeutic results of enzyme substitution].
    Steensberg J; Nielsen KG; Brandt NJ
    Ugeskr Laeger; 1998 Jun; 160(26):3929-30. PubMed ID: 9656836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gaucher's disease: report of 11 cases with review of literature.
    Essabar L; Meskini T; Lamalmi N; Ettair S; Erreimi N; Mouane N
    Pan Afr Med J; 2015; 20():18. PubMed ID: 25995815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enzyme substitution in Gauscher disease].
    Steensberg J; Nielsen KG; Brandt NJ
    Ugeskr Laeger; 1998 Jun; 160(26):3900-3. PubMed ID: 9656829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Type I Gaucher's disease: clinical, evolutive and therapeutic features in 8 cases].
    Giraldo P; Pérez-Calvo J; Cortés T; Civeira F; Rubio-Félix D
    Sangre (Barc); 1994 Feb; 39(1):3-7. PubMed ID: 8197516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months].
    Versteegh C; Avni F; Cuvelier P; Ferster A
    Arch Pediatr; 1998 Dec; 5(12):1341-3. PubMed ID: 9885741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Safety of use of velaglucerase in 2 patients with type 1 Gaucher's disease].
    Latre P; Giraldo P
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():39-42. PubMed ID: 22230124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the densitometric method of hand bone radiograms and assessment of early changes of bone structure in the children with Gaucher's disease on enzyme replacement therapy (ERT)].
    Łyson-Wojciechowska G; Skawiński W; Tylki-Szymańska A
    Pediatr Endocrinol Diabetes Metab; 2007; 13(4):218-223. PubMed ID: 18183671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary hypertension in Gaucher's disease.
    Pastores GM; Miller A
    Lancet; 1998 Aug; 352(9127):580. PubMed ID: 9716094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.